Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521385 · ClinicalTrials.gov registry record · NA
Comparison of Non-invasive Respiratory Monitoring System (RMS) to Capnography for Respiratory Rate (RR)
A NA study of Respiratory Monitoring, sponsored by Makani Science.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06521385: Completed NA study of Respiratory Monitoring, sponsored by Makani Science.
NCT06521385 is a NA study of Respiratory Monitoring that has completed, run by Makani Science. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06521385, a NA study of Respiratory Monitoring, has completed, sponsored by Makani Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the performance of a novel non-invasive respiratory monitoring system against the gold standard methods (capnography) in human subjects. The main question it aims to answer is whether the novel monitoring system comparable to the current standards.
Primary Outcome
Mean absolute error (MAE) was calculated for concurrent respiratory rate measurements obtained from the Makani Science system (experimental device) and capnography (reference device). MAE was defined as the average of the absolute differences between the experimental and reference measurements. The lower and upper bounds of the 95% confidence interval were also calculated for each MAE. Device performance was considered acceptable if the MAE was within 3 breaths per minute (BPM) of the reference
Conditions Studied
Interventions
- DEVICE Makani Science Respiratory Monitoring System
Study Locations (1)
California
- Illumination Foundation - Fullerton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-05-17 |
| Est. Completion | 2024-07-02 |
| Phase | NA |
What the finished NCT06521385 record still lists
NCT06521385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Respiratory Monitoring appearing as the primary indexed condition, and to 1 intervention - of which Makani Science Respiratory Monitoring System is the first listed.
NCT06521385 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06521385 about?
NCT06521385 is a clinical study titled "Comparison of Non-invasive Respiratory Monitoring System (RMS) to Capnography for Respiratory Rate (RR)". The goal of this clinical trial is to compare the performance of a novel non-invasive respiratory monitoring system against the gold standard methods (capnography) in human subjects. The main question it aims to answer is whether the novel monitoring system comparable to the current standards.
What is the current status of trial NCT06521385?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-05-17. Estimated completion is 2024-07-02.
What conditions does trial NCT06521385 study?
This clinical trial studies the following conditions: Respiratory Monitoring.
What interventions are being tested in trial NCT06521385?
The interventions under investigation include: Makani Science Respiratory Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT06521385?
This trial is sponsored by Makani Science, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06521385 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06521385's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI